City

Columbus (3)

Boston (1)

Cincinnati (1)

Dallas (1)

Houston (1)

Krakow (1)

Seattle (1)

Overall Status

Recruiting (2)

Completed (1)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (1)

National Cancer Institute (NCI) (1)

Vincerx Pharma, Inc. (1)

Collaborator

Genentech, Inc. (1)

Intervention

da-epoch-r (1)

laboratory biomarker analysis (1)

lenalidomide (1)

pharmacological study (1)

r-chop (1)

venetoclax (1)

vip152 (1)

Study Documents

Intervention Type

drug (3)

other (2)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

richter syndrome

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Richter Syndrome Trial in United States (Venetoclax, DA-EPOCH-R, R-CHOP)

Recruiting

Richter Syndrome

Venetoclax
+2 more

Boston, Massachusetts
+2 more

Jan 6, 2023

Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

Recruiting

Relapsed Non Hodgkin Lymphoma
+6 more

VIP152

Cincinnati, Ohio
+4 more

Aug 3, 2022

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid

Completed

Adult Acute Myeloid Leukemia in Remission
+41 more

Laboratory Biomarker Analysis
+2 more

Columbus, Ohio

Ohio State University Comprehensive Cancer Center

Sep 22, 2017